Our study provides the first evidence that MSC-derived MMP14 promotes AML cell growth and chemotherapy resistance via the secretion of PGE2, which activates the JAK-STAT pathway, consequently leading to AML progression. This evidence concerns the gene MMP14 and acute myeloid leukemia.